Skip to main content
Equibles
TCRT logo

TCRT · Alaunos Therapeutics, Inc.

Track TCRT — free Ask ALVIS about TCRT
$1.84 -0.06 (-3.16%)
Going-concern doubt — flagged May 15, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We require substantial additional financial resources to continue as a going concern and advance our Obesity and Metabolic Disorders Program; the failure to obtain it on acceptable terms would materially harm our business.”
View the 10-Q filed May 15, 2026
Market Cap
$46.40M
Shares
24.42M

Alaunos Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Alaunos Therapeutics, Inc. (TCRT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$15.75M '19 Q4 20-03-02 · $398,000 −$22.73M '21 Q3 21-09-30 · $ −$11.79M '21 Q4 22-03-30 LATEST ▲631.4% $2.91M −$8.85M '22 Q3 22-11-14
Earnings call
FY23 · Q1
2023-05-10
Alaunos Therapeutics, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-6.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Alaunos Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Alaunos Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$2.91M
▲ 631.4% YoY
Diluted EPS
$-6.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Alaunos Therapeutics, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-7.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Alaunos Therapeutics, Inc. Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-30
Alaunos Therapeutics, Inc. Q4 FY2021 Earnings Call
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Alaunos Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$398,000
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Alaunos Therapeutics, Inc. Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Alaunos Therapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Alaunos Therapeutics, Inc. Q4 FY2020 Earnings Call
Diluted EPS
$-16.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Alaunos Therapeutics, Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Alaunos Therapeutics, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Alaunos Therapeutics, Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-02
Alaunos Therapeutics, Inc. Q4 FY2019 Earnings Call
Revenue
$*
Diluted EPS
$-13.50
▼ 107% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–14 of 14 earnings calls
Key facts CIK 1107421 CUSIP 98973P309 13F (30d) 6 filings 6 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)